Centessa Pharmaceuticals (CNTA) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.67.
- Centessa Pharmaceuticals' Equity Ratio fell 1782.64% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year decrease of 1782.64%. This contributed to the annual value of 0.7 for FY2024, which is 615.71% up from last year.
- Per Centessa Pharmaceuticals' latest filing, its Equity Ratio stood at 0.67 for Q3 2025, which was down 1782.64% from 0.7 recorded in Q2 2025.
- Centessa Pharmaceuticals' Equity Ratio's 5-year high stood at 0.82 during Q1 2022, with a 5-year trough of 0.66 in Q1 2024.
- In the last 4 years, Centessa Pharmaceuticals' Equity Ratio had a median value of 0.72 in 2024 and averaged 0.73.
- Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 1909.68% in 2024, then plummeted by 1782.64% in 2025.
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' Equity Ratio stood at 0.76 in 2022, then fell by 13.33% to 0.66 in 2023, then grew by 6.16% to 0.7 in 2024, then fell by 3.37% to 0.67 in 2025.
- Its Equity Ratio stands at 0.67 for Q3 2025, versus 0.7 for Q2 2025 and 0.73 for Q1 2025.